Abstract Purpose of Review Observational studies and meta-analyses of randomized clinical
trials data have revealed a 10–12% increased risk of new-onset diabetes (NOD) associated …

Statins, with their lipid‐lowering properties, are a first‐line therapy for the prevention of
cardiovascular diseases. Recent evidence, however, suggests that statins can increase the …

Objective To evaluate the association between statin use and risk of biliary tract cancers
(BTC). Design This is a nested case–control study conducted in the UK Clinical Practice …

Prescription of cardiovascular drugs is aimed at preventing and treating morbid conditions
affecting the cardiovascular system. However, apart from their primary therapeutic target …

Elevated plasma low density lipoprotein (LDL) is an established risk factor for cardiovascular
disease. In addition to being able to cross the endothelial barrier to become accumulated in …

The diagnostic criteria for diabetes mellitus (DM) have undergone a sea change over the
last several decades. The specific cutoff points for diagnosing DM still remain a matter of …

Background HMG-CoA reductase inhibitors (statins) are cholesterol-lowering drugs widely
used to treat hypercholesterolemia and prevent cardiovascular disease. Statins are …

The present article reviews evidence about the effect of statins on the risk of developing
diabetes mellitus (DM). A literature search was performed using databases of biomedical …

No âmbito da unidade curricular Estágio Curricular do Mestrado Integrado em
CiênciasFarmacêuticas da Faculdade de Farmácia da Universidade de Coimbra, o …

Представлен научный обзор данных о влиянии статинов на риск развития сахарного
диабета (СД), согласно доказательствам разного уровня. Проведен поиск зарубежных …